The Role of 18F-FDG PET/CT in the Evaluation of Solid Splenic Masses

Ur Metser*, Einat Even-Sapir

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

18F-Fluorodeoxyglucose-positron emission tomography/computed tomography is a noninvasive imaging modality that appears to have a high negative-predictive value for malignancy in assessing solid splenic masses discovered on conventional imaging modalities. Histological sampling is recommended for fluorodeoxyglucose-avid splenic masses, as the main differential diagnosis includes malignancy, either primary or secondary, or granulomatous disease.

Original languageEnglish
Pages (from-to)420-425
Number of pages6
JournalSeminars in Ultrasound, CT and MRI
Volume27
Issue number5
DOIs
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'The Role of 18F-FDG PET/CT in the Evaluation of Solid Splenic Masses'. Together they form a unique fingerprint.

Cite this